// App-Quantinova.ai

4911 : SOCS-1 inhibits tumor growth by enhancing T cell mediated antitumor immunity related to PD-L1

Researchers

Presenter

  • Satoshi Nakagawa

Principal Investigators

  • Satoshi Serada

  • Satoko Matsuzaki

  • Yutaka Ueda

  • Kiyoshi Yoshino

  • Minoru Fujimoto

  • Tadashi Kimura

  • Tetsuji Naka

Medical Centers

  • Kinki University, Osaka, Japan

  • National Institute of Biomedical Innovation, Ibaraki,Osaka, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved